General Information
Version
8.3
Revision date
2024-07-02
Product name
Rifampicin
CAS No.
13292-46-1
1.2.1 Relevant identified uses
Reagent for development and research
Emergency telephone
+64 9 801 0034
Icons in SDS
Company Information
company name
Merck Life Science Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
customersupport.anz@merckgroup.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H315, H319, H334, H351, H361, H371
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Acute toxicity, Oral (Category 4), H302 Skin corrosion/irritation (Category 2), H315 Serious eye damage/eye irritation (Category 2), H319 Respiratory sensitization (Category 1), H334 Carcinogenicity (Category 2), H351 Reproductive toxicity (Category 2), H361 Specific target organ toxicity - single exposure, Oral (Category 2), H371 For the full text of the H-Statements mentioned in this Section, see Section 16.
Signal word
Danger
Hazard statements
H302 Harmful if swallowed. H315 Causes skin irritation. H319 Causes serious eye irritation. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H351 Suspected of causing cancer. H361 Suspected of damaging fertility or the unborn child. H371 May cause damage to organs if swallowed.
Prevention
P201 Obtain special instructions before use. P260 Do not breathe dust. P264 Wash skin thoroughly after handling. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection.
Response
P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTER/ doctor.
Other hazards
- none
